The list of recommendations included laws to allow Medicare to negotiate prices, permit cancer drug imports, and prevent companies from delaying access to generic drugs.

According to a report published in Mayo Clinic Proceedings in 2012, four doses of one particular cancer drug costs a staggering $120,000.
“It’s time for patients and their physicians to call for change,” said Dr Ayalew Tefferi, a Mayo Clinic hematologist.
The recommendations included a proposal to allow individuals to import cancer drugs from other countries, where the drug is far cheaper, to allow Medicare to negotiate prices.
Other recommendations include creating a regulatory body that would propose fair pricing after a drug gains approval by the Food and Drug Administration, and also prevent pharmaceutical companies from delaying access to generic drugs.
“It’s time for patients and their physicians to call for change,” said Dr Tefferi.
MEDINDIA




Email










